FOXP1 and breast cancer: Similar results were obtained by immunofluorescence staining, with FOXP1 significantly accumulated in nucleus of adipocytes after cocultivated with breast cancer cells, while the PI3K/AKT inhibitor or tiplaxtinin decreased the distribution of FOXP1 in the nucleus (Fig. 6g).